tiprankstipranks
Lifecore Biomedical, Inc. (LFCR)
NASDAQ:LFCR
US Market
LFCR
Lifecore Biomedical
RESEARCH TOOLSreports
Want to see LFCR full AI Analyst Report?

Lifecore Biomedical (LFCR) Ratios

153 Followers

Lifecore Biomedical Ratios

LFCR's free cash flow for Q3 2026 was $0.19. For the 2026 fiscal year, LFCR's free cash flow was decreased by $ and operating cash flow was $-0.20. See a summary of the company’s cash flow.
Ratios
TTM
May 25May 24Aug 23May 22
Liquidity Ratios
Current Ratio
 3.79 2.84 2.08 2.39 0.66
Quick Ratio
 2.41 1.77 1.06 1.35 0.46
Cash Ratio
 1.01 0.27 0.22 0.49 <0.01
Solvency Ratio
 -0.12 -0.13 0.08 -0.34 -0.53
Operating Cash Flow Ratio
 0.85 >-0.01 <0.01 -0.44 -0.13
Short-Term Operating Cash Flow Coverage
 13.00 -0.06 0.27 -30.07 -0.16
Net Current Asset Value
$ -127.08M$ -152.33M$ -161.61M$ -163.90M$ -70.21M
Leverage Ratios
Debt-to-Assets Ratio
 0.67 0.55 0.53 0.44 0.90
Debt-to-Equity Ratio
 7.23 97.92 11.81 -26.63 2.82
Debt-to-Capital Ratio
 0.88 0.99 0.92 1.04 0.74
Long-Term Debt-to-Capital Ratio
 0.87 0.99 0.92 1.04 0.53
Financial Leverage Ratio
 10.85 179.15 22.44 -59.94 3.13
Debt Service Coverage Ratio
 0.10 -0.35 1.86 -1.84 0.12
Interest Coverage Ratio
 >-0.01 -0.79 -0.49 -1.23 -0.76
Debt to Market Cap
 0.84 0.56 0.73 0.43 0.81
Interest Debt Per Share
 4.62 4.38 4.98 4.35 8.94
Net Debt to EBITDA
 47.43 -13.91 3.51 -2.82 19.21
Profitability Margins
Gross Profit Margin
31.17%31.27%32.63%27.10%35.11%
EBIT Margin
-5.21%-13.07%21.52%-44.88%-4.69%
EBITDA Margin
2.02%-6.84%27.76%-32.12%11.54%
Operating Profit Margin
-0.06%-13.38%-6.90%-21.11%-10.60%
Pretax Profit Margin
-24.92%-30.01%7.42%-61.90%-18.59%
Net Profit Margin
-25.22%-30.04%9.37%-96.41%-104.89%
Continuous Operations Profit Margin
-25.22%-30.04%7.28%-62.20%-13.91%
Net Income Per EBT
101.23%100.11%126.27%155.74%564.19%
EBT Per EBIT
43173.08%224.26%-107.58%293.30%175.45%
Return on Assets (ROA)
-15.12%-16.18%4.73%-39.27%-42.49%
Return on Equity (ROE)
-146.68%-2897.98%106.17%2353.74%-132.90%
Return on Capital Employed (ROCE)
-0.04%-8.24%-4.11%-10.17%-12.02%
Return on Invested Capital (ROIC)
-0.04%-8.10%-3.94%-10.09%-3.67%
Return on Tangible Assets
-16.11%-17.50%5.09%-42.28%-45.48%
Earnings Yield
-19.90%-16.55%7.01%-41.86%-40.13%
Efficiency Ratios
Receivables Turnover
 5.03 2.95 4.12 3.56 2.90
Payables Turnover
 14.01 10.77 5.29 3.41 5.57
Inventory Turnover
 3.30 2.74 2.16 1.84 2.01
Fixed Asset Turnover
 1.08 1.00 0.86 0.74 0.90
Asset Turnover
 0.60 0.54 0.51 0.41 0.41
Working Capital Turnover Ratio
 2.33 2.64 2.65 -38.77 -16.51
Cash Conversion Cycle
 157.03 222.88 188.53 193.46 242.19
Days of Sales Outstanding
 72.61 123.68 88.65 102.58 125.68
Days of Inventory Outstanding
 110.47 133.07 168.87 198.01 181.98
Days of Payables Outstanding
 26.05 33.88 68.99 107.13 65.47
Operating Cycle
 183.08 256.76 257.53 300.59 307.67
Cash Flow Ratios
Operating Cash Flow Per Share
 0.46 >-0.01 <0.01 -0.58 -0.77
Free Cash Flow Per Share
 0.28 -0.39 -0.60 -1.30 -1.78
CapEx Per Share
 0.18 0.39 0.60 0.72 1.02
Free Cash Flow to Operating Cash Flow
 0.60 66.12 -70.58 2.23 2.33
Dividend Paid and CapEx Coverage Ratio
 2.51 -0.02 0.01 -0.81 -0.75
Capital Expenditure Coverage Ratio
 2.51 -0.02 0.01 -0.81 -0.75
Operating Cash Flow Coverage Ratio
 0.12 >-0.01 <0.01 -0.15 -0.09
Operating Cash Flow to Sales Ratio
 0.13 >-0.01 <0.01 -0.17 -0.20
Free Cash Flow Yield
6.11%-5.82%-10.59%-16.36%-18.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.02 -6.04 14.26 -2.39 -2.49
Price-to-Sales (P/S) Ratio
 1.27 1.82 1.34 2.30 2.61
Price-to-Book (P/B) Ratio
 8.24 175.14 15.14 -56.23 3.31
Price-to-Free Cash Flow (P/FCF) Ratio
 16.38 -17.18 -9.44 -6.11 -5.54
Price-to-Operating Cash Flow Ratio
 9.86 -1.14K 666.40 -13.64 -12.87
Price-to-Earnings Growth (PEG) Ratio
 -0.14 0.01 -0.13 0.15 >-0.01
Price-to-Fair Value
 8.24 175.14 15.14 -56.23 3.31
Enterprise Value Multiple
 110.29 -40.46 8.32 -9.99 41.86
Enterprise Value
 300.76M 356.54M 296.38M 331.40M 537.62M
EV to EBITDA
 110.29 -40.46 8.32 -9.99 41.86
EV to Sales
 2.23 2.77 2.31 3.21 4.83
EV to Free Cash Flow
 28.74 -26.18 -16.34 -8.51 -10.23
EV to Operating Cash Flow
 17.31 -1.73K 1.15K -19.00 -23.80
Tangible Book Value Per Share
 0.18 -0.48 -0.22 -0.74 2.37
Shareholders’ Equity Per Share
 0.55 0.04 0.37 -0.14 2.98
Tax and Other Ratios
Effective Tax Rate
 -0.01 >-0.01 0.02 >-0.01 0.25
Revenue Per Share
 3.61 3.70 4.21 3.45 3.78
Net Income Per Share
 -0.91 -1.11 0.39 -3.32 -3.96
Tax Burden
 1.01 1.00 1.26 1.56 5.64
Interest Burden
 4.78 2.30 0.34 1.38 3.97
Research & Development to Revenue
 0.06 0.06 0.07 0.08 0.07
SG&A to Revenue
 0.25 0.34 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.08 0.05 0.03 0.02
Income Quality
 -0.51 <0.01 0.02 0.18 0.19
Currency in USD